Oral microbial taxa associated with risk for SARS-CoV-2 infection

被引:2
|
作者
Callahan, Nicholas [1 ]
Hattar, Meryana [2 ]
Barbour, Thawab [2 ]
Adami, Guy R. R. [2 ]
Kawar, Nadia [3 ]
机构
[1] Univ Illinois, Coll Dent, Dept Oral & Maxillofacial Surg, Chicago, IL USA
[2] Univ Illinois, Coll Dent, Dept Oral Med & Diagnost, Chicago, IL 60607 USA
[3] Univ Illinois, Coll Dent, Dept Periodont, Chicago, IL USA
来源
关键词
bacteria; COVID-19; risk; Neisseria elongata; 16S rRNA (16S rDNA); oral microbiota; COVID-19;
D O I
10.3389/froh.2022.886341
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Hypothesis and objectiveThe oral and digestive tract microbial ecosystem has sparked interest because of its impact on various systemic diseases and conditions. The oral cavity serves not only as a reservoir for many potentially virulent microbiota but also as an important entry point and portal to the human body system. This is especially significant in the transmissibility of the virulent current pandemic virus SARS-CoV-2. The oral and digestive microbiome influences the inflammatory burden and effectiveness of the immune system and serves as a marker of activity of these host processes. The host immune response plays a role in infection susceptibility, including SARS-CoV-2. The purpose of this study is to investigate the role of specific salivary oral microbiome in susceptibility to SARS-CoV-2 infection. Methods and resultsOne hundred six subjects of known medical and dental history who consented to provide saliva samples between January 2017 and December 2019 were included in this study. Sixteen had become COVID-19 positive based on the PCR test by 3/01/2021. A comparison of oral microbiome bacteria taxa profiles based on 16S rRNA sequencing revealed differences between the two groups in this pilot study. ConclusionsThese bacteria taxa may be markers of increased susceptibility to SARS-CoV-2 infection in the unvaccinated population.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Urticaria and angioedema associated with SARS-CoV-2 infection
    Zipursky, Jonathan S.
    Croitoru, David
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (45) : E1752 - E1753
  • [32] Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection
    Labo, Nazzarena
    Ohnuki, Hidetaka
    Tosato, Giovanna
    CELLS, 2020, 9 (07)
  • [33] Risk and protective factors of SARS-CoV-2 infection
    Takagi, Hisato
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (02) : 649 - 651
  • [34] Persistent SARS-CoV-2 infection and the risk for cancer
    Alpalhao, Miguel
    Ferreira, Joao Augusto
    Filipe, Paulo
    MEDICAL HYPOTHESES, 2020, 143
  • [35] Oral ulcer in SARS-CoV-2 infection: a case report
    Rapp, Lucie
    Gemar, Thomas
    Lacoste-Ferre, Marie-Helene
    AME CASE REPORTS, 2024, 8
  • [36] Oral erosions and petechiae during SARS-CoV-2 infection
    Ciccarese, Giulia
    Drago, Francesco
    Boatti, Martina
    Porro, Alice
    Muzic, Shaun Ivan
    Parodi, Aurora
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (01) : 129 - 132
  • [37] Oral dysbiosis and its linkage with SARS-CoV-2 infection
    Gupta, Abhishek
    Bhanushali, Shivang
    Sanap, Avinash
    Shekatkar, Madhura
    Kharat, Avinash
    Raut, Chandrashekhar
    Bhonde, Ramesh
    Shouche, Yogesh
    Kheur, Supriya
    Sharma, Avinash
    MICROBIOLOGICAL RESEARCH, 2022, 261
  • [38] Oral antivirals for the prevention and treatment of SARS-CoV-2 infection
    Soriano, Vicente
    de-Mendoza, Carmen
    Edagwa, Benson
    Trevino, Ana
    Barreiro, Pablo
    Fernandez-Montero, Jose, V
    Gendelman, Howard E.
    AIDS REVIEWS, 2022, 24 (01) : 41 - 49
  • [39] The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
    Xia, Yong
    Hong, Honghai
    Feng, Yao
    Liu, Meiling
    Pan, Xingfei
    Chen, Dexiong
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 96 : 359 - 360
  • [40] Risk factors associated with SARS-CoV-2 infection among health professionals in Spain
    Valera Felices, J. L.
    Gimeno Cardells, A.
    Gimeno Peribanez, M. A.
    Diaz-Perez, D.
    Miranda Valladares, S.
    Pena-Otero, D.
    ANALES DEL SISTEMA SANITARIO DE NAVARRA, 2021, 44 (03) : 397 - 404